All Articles

A landmark $1.5 billion financing deal for Aypa Power signals a new era for energy storage, accelerating the race to build a more resilient U.S. power grid.

A breakthrough in cancer therapy as Avacta's faridoxorubicin proves so safe, regulators have removed historic dosing limits tied to heart toxicity.

At DISTRIBUTECH 2026, Anterix unveiled a new brand, moving beyond spectrum to deliver integrated private wireless solutions for utility grid modernization.

Current blood thinners carry a risky trade-off. A new class of drugs targeting Factor XIa could prevent deadly clots without the dangerous bleeding.

In a crowded AI market, ActiveCampaign is betting on self-evaluation. Its acquisition of Feedback Intelligence aims to create AI that learns and improves.

PayPal replaces its CEO after just 16 months, bringing in HP's Enrique Lores to combat slowing growth and fierce competition in the digital payments race.

This Valentine's, the arcade giant is turning its viral Human Crane into a high-stakes proposal. But is winning a diamond ring as simple as 'play to win'?

Industrial giant AMETEK acquires LKC Technologies, aiming to revolutionize eye care with portable diagnostic devices for early disease detection.

Relay Therapeutics' experimental drug, zovegalisib, offers new hope for a common and hard-to-treat form of advanced breast cancer with a promising safety profile.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.

A landmark deal will connect Visa Direct to billions of UnionPay cards, set to revolutionize global remittances into one of the world's largest economies.

A new report reveals a widening gap in auto insurance rates. While some states see relief, others face crippling price hikes. Find out why and what you can do.

Arbor Realty Trust earned a key Fitch upgrade for its special servicer capabilities, citing tech and expertise, even as market watchers focus on credit quality.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

Keeper's new 2026 partner program offers tiered incentives and a cloud-native platform, aiming to make enterprise-grade privileged access management profitable for MSPs.

The convenience store giant released preliminary 2025 financials as its subsidiary, ARKO Petroleum Corp., launches a high-stakes IPO roadshow.

A new AI-powered blood test from CareDx shows promise in detecting cancer relapse weeks earlier, offering new hope for transplant patients.

At NADA 2026, Pinewood.AI unveiled Pi, an AI agent that automates tasks in existing browsers, signaling a major shift in dealership operations and workforce roles.

Promega's new diagnostic for KEYTRUDA gains NMPA approval, opening doors for targeted solid tumor therapy amid China's growing precision medicine market.

At a critical juncture, Abcourt Mines brings a long-time consultant in-house, betting his expertise can overcome financial hurdles and unlock project value.